All regulations
Rulemaking
FDA
RIN Not Assigned
FDA-2026-N-7627
Medical Devices; General Hospital and Personal Use Devices; Classification of the Diabetes Digital Behavioral Therapeutic Device
Documents
1
Comments
0
Description
The Food and Drug Administration (FDA) is classifying the diabetes digital behavioral therapeutic device into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the diabetes digital behavioral therapeutic device. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients’ access to beneficial innovative devices, in part by reducing regulatory burdens.
Key Dates
Comment Period OpensJul 24, 2026
Documents
| Type | Title | Status |
|---|---|---|
Final Rule |
Keywords
CDRH
FRDTS # 2026-278
Medical Devices
General Hospital and Personal Use Devices
Classification of the Diabetes Digital
Behavioral Therapeutic Device
Open
Data from Regulations.gov